The prostate cancer progression has been related to many factors such as inflammation [1] and the so-called angiogenic switch that implies enhanced angiogenesis, characterized by high vascular endothelial growth factor (VEGF) and VEGF receptor (VEGFR) levels [2]. This evidence concerns the gene KDR and Familial prostate cancer.